InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Morrison Jodie Pope. Officer active across 2 companies, notably Tokai Pharmaceuticals Inc. In total, 9 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €261k. History available since 24 February 2025. The latest transaction was disclosed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Morrison Jodie Pope is a declarant linked to Q32 Bio Inc. and Tokai Pharmaceuticals Inc, where the listed role is CEO for the former and President and CEO for the latter. Across 8 filings in total, the 8 sampled filings run from 2016-01-08 to 2026-07-20 and show EUR 0 in buys and EUR 121263 in sells, with transaction nature listed as Attribution.